Halozyme schedules third-quarter 2026 results release

HALO•2026-10-22

Halozyme Therapeutics will release its third-quarter 2026 results after trading closes on November 5 and hold a conference call at 1:30 p.m. PT/4:30 p.m. ET that day.

1. Results and call scheduled

Halozyme Therapeutics will release its third-quarter 2026 financial and operating results after the close of trading on November 5, 2026. A conference call to discuss the results is scheduled for 1:30 p.m. PT/4:30 p.m. ET that day.

Halozyme schedules third-quarter 2026 results release

1. Results and call scheduled

Related News

Redington Gulf signs strategic collaboration agreement with AWS for AI adoption in META region

Data443 launches Convaa.ai collaboration platform for regulated enterprises

Zillow: Hidden costs of US homeownership rise 32% in five years

B. Riley raises Veradermics target price to $204 from $170

NetScout publishes update to financial calendar